craft-sa-dev Home  

PMC:1283364 / 1669-2079 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T419 0-10 NN denotes Conclusion
T420 10-142 sentence denotes This study demonstrates that amyloid lesions in transgenic mice are highly stable structures in vivo that are slow to disaggregate.
T421 11-15 DT denotes This
T422 16-21 NN denotes study
T423 22-34 VBZ denotes demonstrates
T424 35-39 IN denotes that
T426 40-47 NN denotes amyloid
T427 48-55 NNS denotes lesions
T428 56-58 IN denotes in
T429 59-69 JJ denotes transgenic
T430 70-74 NNS denotes mice
T425 75-78 VBP denotes are
T431 79-85 RB denotes highly
T432 86-92 JJ denotes stable
T433 93-103 NNS denotes structures
T434 104-106 FW denotes in
T435 107-111 FW denotes vivo
T436 112-116 WDT denotes that
T437 117-120 VBP denotes are
T438 121-125 JJ denotes slow
T439 126-128 TO denotes to
T440 129-141 VB denotes disaggregate
T441 141-142 . denotes .
T442 142-410 sentence denotes Our findings suggest that arresting Aβ production in patients with Alzheimer disease should halt the progression of pathology, but that early treatment may be imperative, as it appears that amyloid deposits, once formed, will require additional intervention to clear.
T443 143-146 PRP$ denotes Our
T444 147-155 NNS denotes findings
T445 156-163 VBP denotes suggest
T446 164-168 IN denotes that
T448 169-178 VBG denotes arresting
T449 179-181 NN denotes Aβ
T450 182-192 NN denotes production
T451 193-195 IN denotes in
T452 196-204 NNS denotes patients
T453 205-209 IN denotes with
T454 210-219 NNP denotes Alzheimer
T455 220-227 NN denotes disease
T456 228-234 MD denotes should
T447 235-239 VB denotes halt
T457 240-243 DT denotes the
T458 244-255 NN denotes progression
T459 256-258 IN denotes of
T460 259-268 NN denotes pathology
T461 268-270 , denotes ,
T462 270-273 CC denotes but
T463 274-278 IN denotes that
T465 279-284 JJ denotes early
T466 285-294 NN denotes treatment
T467 295-298 MD denotes may
T464 299-301 VB denotes be
T468 302-312 JJ denotes imperative
T469 312-314 , denotes ,
T470 314-316 IN denotes as
T472 317-319 PRP denotes it
T471 320-327 VBZ denotes appears
T473 328-332 IN denotes that
T475 333-340 NN denotes amyloid
T476 341-349 NNS denotes deposits
T477 349-351 , denotes ,
T478 351-355 IN denotes once
T479 356-362 VBN denotes formed
T480 362-364 , denotes ,
T481 364-368 MD denotes will
T474 369-376 VB denotes require
T482 377-387 JJ denotes additional
T483 388-400 NN denotes intervention
T484 401-403 TO denotes to
T485 404-409 VB denotes clear
T486 409-410 . denotes .
R256 T421 T422 det This,study
R257 T422 T423 nsubj study,demonstrates
R258 T424 T425 mark that,are
R259 T425 T423 ccomp are,demonstrates
R260 T426 T427 compound amyloid,lesions
R261 T427 T425 nsubj lesions,are
R262 T428 T427 prep in,lesions
R263 T429 T430 amod transgenic,mice
R264 T430 T428 pobj mice,in
R265 T431 T432 advmod highly,stable
R266 T432 T433 amod stable,structures
R267 T433 T425 attr structures,are
R268 T434 T435 advmod in,vivo
R269 T435 T433 advmod vivo,structures
R270 T436 T437 dep that,are
R271 T437 T433 relcl are,structures
R272 T438 T437 acomp slow,are
R273 T439 T440 aux to,disaggregate
R274 T440 T438 xcomp disaggregate,slow
R275 T441 T423 punct .,demonstrates
R276 T443 T444 poss Our,findings
R277 T444 T445 nsubj findings,suggest
R278 T446 T447 mark that,halt
R279 T447 T445 advcl halt,suggest
R280 T448 T447 csubj arresting,halt
R281 T449 T450 compound Aβ,production
R282 T450 T448 dobj production,arresting
R283 T451 T448 prep in,arresting
R284 T452 T451 pobj patients,in
R285 T453 T452 prep with,patients
R286 T454 T455 compound Alzheimer,disease
R287 T455 T453 pobj disease,with
R288 T456 T447 aux should,halt
R289 T457 T458 det the,progression
R290 T458 T447 dobj progression,halt
R291 T459 T458 prep of,progression
R292 T460 T459 pobj pathology,of
R293 T461 T447 punct ", ",halt
R294 T462 T447 cc but,halt
R295 T463 T464 mark that,be
R296 T464 T447 conj be,halt
R297 T465 T466 amod early,treatment
R298 T466 T464 nsubj treatment,be
R299 T467 T464 aux may,be
R300 T468 T464 acomp imperative,be
R301 T469 T464 punct ", ",be
R302 T470 T471 mark as,appears
R303 T471 T464 advcl appears,be
R304 T472 T471 nsubj it,appears
R305 T473 T474 mark that,require
R306 T474 T471 ccomp require,appears
R307 T475 T476 compound amyloid,deposits
R308 T476 T474 nsubj deposits,require
R309 T477 T474 punct ", ",require
R310 T478 T479 mark once,formed
R311 T479 T474 advcl formed,require
R312 T480 T474 punct ", ",require
R313 T481 T474 aux will,require
R314 T482 T483 amod additional,intervention
R315 T483 T474 dobj intervention,require
R316 T484 T485 aux to,clear
R317 T485 T483 advcl clear,intervention
R318 T486 T445 punct .,suggest